Share Facebook Twitter LinkedIn Pinterest Email Palvella Therapeutics registers 5.6M shares by selling holders
CMB.TECH forecasts $700M-$1B 2027 operational cash flow after CapEx, while repaying September bond from cash (NYSE:CMBT)August 27, 2026